Wide-field-of-view mesoscopic cortical imaging with genetically encoded sensors enables decoding of regional activity and connectivity in anesthetized and behaving mice; however, the kinetics of most genetically encoded sensors can be suboptimal for in vivo characterization of frequency bands higher than 1-3 Hz. Furthermore, existing sensors, in particular those that measure calcium (genetically encoded calcium indicators; GECIs), largely monitor suprathreshold activity. Using a genetically encoded sensor of extracellular glutamate and in vivo mesoscopic imaging, we demonstrate rapid kinetics of virally transduced or transgenically expressed glutamate-sensing fluorescent reporter iGluSnFR. In both awake and anesthetized mice, we imaged an 8 ϫ 8 mm field of view through an intact transparent skull preparation. iGluSnFR revealed cortical representation of sensory stimuli with rapid kinetics that were also reflected in correlation maps of spontaneous cortical activities at frequencies up to the alpha band (8 -12 Hz). iGluSnFR resolved temporal features of sensory processing such as an intracortical reverberation during the processing of visual stimuli. The kinetics of iGluSnFR for reporting regional cortical signals were more rapid than those for Emx-GCaMP3 and GCaMP6s and comparable to the temporal responses seen with RH1692 voltage sensitive dye (VSD), with similar signal amplitude. Regional cortical connectivity detected by iGluSnFR in spontaneous brain activity identified functional circuits consistent with maps generated from GCaMP3 mice, GCaMP6s mice, or VSD sensors. Viral and transgenic iGluSnFR tools have potential utility in normal physiology, as well as neurologic and psychiatric pathologies in which abnormalities in glutamatergic signaling are implicated.
Introduction
One of the goals in neurophysiology is to acquire in vivo real-time measures of ongoing neuronal activity (Knöpfel et al., 2006; Akemann et al., 2010; Chen et al., 2013b; Stroh et al., 2013; Madisen et al., 2015) . When making such measurements, one needs to be aware of potential limitations in monitoring approaches. Currently, the standard for electrophysiological assessment is the measurement of transmembrane voltage using an intracellular electrode or extracellu-lar potentials using electrodes. However, microelectrode-based methods are limited due to the small number of cells that can be simultaneously recorded. Voltage-sensitive dyes (VSDs) provide cellular and regional measures of neuronal excitation and inhibition (Grinvald and Hildesheim, 2004; Ferezou et al., 2007; Akemann et al., 2010) , but are not direct measures of synaptic activity. Calcium indicators provide exquisite sensitivity due to relatively large changes of indicator fluorescence associated with physiological Ca 2ϩ transients (Grynkiewicz et al., 1985; . Although calcium indicator signals can be large, they can nonlinearly relate to calcium concentration (Rose et al., 2014) , which in turn has a complex relationship to membrane voltage (Berger et al., 2007) . Furthermore, the signals of genetically encoded calcium-indicators (GECIs) have relatively slow kinetics, limiting their use in multicell-imaging applications to detection of spike-related signals at low frequencies. In addition, Ca 2ϩ imaging is most appropriate for monitoring suprathreshold events (Chen et al., 2013b) . Despite the limiting kinetics of calcium modalities, the current generation of intracellular calcium sensors are more than sufficient for mapping neuronal activity with low time resolution on the order of seconds Chen et al., 2013b; Vanni and Murphy, 2014 ), but may not directly follow higher-frequency circuit dynamics.
Recently, organic dyes or genetically encoded sensors for neurotransmitters, including the major excitatory neurotransmitter glutamate, have been developed (Hires et al., 2008; Okubo et al., 2010; Marvin et al., 2013) . Here, we use a genetically encoded glutamate sensor, iGluSnFR , in vivo to assess cortical activity and intracortical functional connectivity. iGluSnFR is targeted to neurons and detects extracellular glutamate concentration with ϳ1 ms rise and 40 ms decay times when tested using glutamate uncaging in vitro . This rise time is much faster than the ϳ10 ms time scale of sensory response rise time measured in vivo using organic VSDs (Ferezou et al., 2007; Sachidhanandam et al., 2013) , indicating that iGluSnFR assessment of sensory processing is not limited by slow kinetics.
A functional marker of glutamate concentration amenable to mesoscopic imaging has several advantages, including detection of an endogenous neurotransmitter with clear functional significance. Indeed, the utility of a glutamate reporter for the characterization of normal and pathologic brain states is obvious due to glutamate's role in synaptic transmission, plasticity, and learning, as well as in illnesses such as stroke or in psychopathology. We report the in vivo characterization of iGluSnFR using both AAVinjected and transgenic mice. Specifically, in both anesthetized and awake states, we used both spontaneous and sensory-evoked activity to characterize the sensitivity, specificity, and kinetics of this new rapid sensor compared with existing sensors.
Materials and Methods
Procedures. All procedures were approved by the University of British Columbia Animal Care Committee and conformed to the Canadian Council on Animal Care and Use guidelines. Mice were housed in clear plastic cages in groups of two to five under a 12 h light, 12 h dark cycle with ad libitum food and water.
Animals. Adult (2-4 month) C57BL/6J mice from Charles River Laboratories were acquired for viral injection experiments and VSD imaging experiments using wide-field epifluorescence imaging (Fig. 1) . Transgenic mice were imaged at adulthood (2-4 month). In all experiments, only male mice were used.
We generated Emx-CaMKII-iGluSnFR transgenic mice by crossing the homozygous B6.129S2-Emx1 tm1(cre)Krj /J strain (Jax no. 005628) and the B6.Cg-Tg(CamK2a-tTA)1Mmay/DboJ strain (Jax no.007004) with the hemizygous B6;129S-Igs7 tm85(teto-iGluSnFR)Hze /J strain (the Allen Institute for Brain Science, Ai85). This crossing is expected to produce expression of iGluSnFR within all excitatory neurons across all layers of the cortex, but not in GABAergic neurons (Gorski et al., 2002; Huang and Zeng, 2013; Madisen et al., 2015) .
We generated Emx-CaMKII-GCaMP6s transgenic mice by crossing the homozygous B6.129S2-Emx1 tm1(cre)Krj /J strain (Jax no. 005628) and the B6.Cg-Tg(CamK2a-tTA)1Mmay/DboJ strain (Jax no.007004) with the hemizygous B6;Cg-Igs7 tm94.1(tetO-GCaMP6s)Hze /J strain (Jax no.024104, Ai94) (Madisen et al., 2015 /J strain (Jax no. 014538, Ai38). Animals with the desired combination of transgenes were selected on the basis of genotyping data (Table 1) .
Viral injection. Viral delivery of iGluSnFR involved 1 l of AAV1.hSyn.iGluSnFR.WPRE.SV40 (Penn Vector Core) injected by a syringe infusion pump (model UMC4; World Precision Instruments) as described previously (Xie et al., 2014) . C57BL/6J mice were injected (depth: ϳ350 m; infusion speed: ϳ1 nl/s) 3-4 weeks before implantation of the cranial window and imaging. Injections were performed at 3 sites: (1) motor cortex (1 mm anterior and 2 mm lateral to bregma); (2) somatosensory cortex (1.5 mm posterior and 2.5 mm lateral to bregma); and (3) visual cortex (3.5 mm posterior and 2 mm lateral to bregma) ( Fig.  2A) . Isoflurane (1.5%) in oxygen was used for anesthesia.
Surgical procedures for implanting chronic transcranial window. To implant chronic windows (Fig. 1B) , animals were anesthetized with isoflurane (1.5% in O 2 ) and body temperature was maintained at 37°C using a feedback-regulated heating pad and monitored by a rectal thermometer. Mice received an intramuscular injection of 40 l of dexamethasone (2 mg/ml) and a 0.5 ml subcutaneous injection of a saline solution containing buprenorphine (2 g/ml), atropine (3 g/ml), and glucose (20 mM) and were placed in a stereotaxic frame. After locally anesthetizing the scalp with lidocaine (0.1 ml, 0.2%), the skin covering the skull was removed and replaced by transparent dental cement (Parkell C&B Metabond) and a glass coverslip (Fig. 1B; Silasi et al., 2013; Vanni and Murphy, 2014) . A 4 -40 metal stud was attached to the skull for future head fixation during recordings. At the end of the procedure, the animal received a second subcutaneous injection of saline (0.5 ml) with 20 mM glucose and recovered in a warmed cage for 30 min. For subsequent chronic recordings, animals were anesthetized with isoflurane (ϳ1.5%) to produce a constant level of cortical activity and the head was stabilized by attaching the bolt to a pole mounted on a base plate. Body temperature was maintained at ϳ37°C and hydration was supported by subcutaneous injection of saline (0.3 ml) with 20 mM glucose at 2 h intervals. In most cases, longitudinal imaging with the chronic window could last Ͼ2 months (Fig. 3E) .
Craniotomy and VSD imaging. VSD imaging was performed in acute experiments as we described previously (Mohajerani et al., 2010 (Mohajerani et al., , 2013 using RH 1692 dye (Optical Imaging; Shoham et al., 1999) . Ten-weekold mice were anesthetized with isoflurane (1.5%) for induction and during craniotomy surgery. Mice were placed on a metal plate that could be mounted onto the stage of the upright macroscope and the skull was fastened to a steel plate. A 7 ϫ 6 mm unilateral craniotomy (bregma 2.5 to Ϫ4.5 mm, lateral 0 -6 mm) or bilateral craniotomy (bregma 2.5 to Ϫ4.5 mm, lateral 0 -3 mm in both sides) was made and the underlying dura was removed. Throughout surgery and imaging, body temperature was maintained at 37°C using a heating pad with a thermistor for feedback. RH-1692 voltage sensitive dye was dissolved in HEPES-buffered saline solution (1 mg/ml) and applied to the exposed cortex for 90 min, which stained all neocortical layers. The brain was covered with 1.5% agarose made in HEPES-buffered saline and sealed with a glass coverslip. VSD was excited with light delivered by a red LED (Luxeon K2, 627 nm center) through a 630 Ϯ 15 nm excitation filter. Ambient light resulting from VSD excitation (630 nm) was ϳ1-2 mW over the 8 ϫ 8 mm area used for imaging. Imaging was performed under light anesthesia (isoflurane, 0.75 ϳ 1%). VSD epifluorescence was imaged through a 688 Ϯ 15 nm band-pass filter (Semrock).
Sensory stimulation and imaging. Images of the cortical surface were projected through a pair of back-to-back photographic lenses (50 mm, 1.4 f:135 mm, 2.8 f or 50 mm, 1.4 f:30 mm, 2 f) onto a 1M60Pantera CCD camera (Dalsa). iGluSnFR and GCaMP were excited with light from a blue-light-emitting diode (Luxeon, 473 nm) delivered through a band-pass filter (Chroma, . Ambient light resulting from iGluSnFR and GCaMPs excitation (473 nm) was ϳ1-2 mW over the 8 ϫ 8 mm area used for imaging. iGluSnFR and GCaMP fluorescence emission was filtered using a 510 -550 nm band-pass filter (Chroma). We collected 12-bit images at 150 Hz using XCAP imaging software (Fig.  1A) . When collecting somatosensory-evoked cortical activity, we used piezoelectric bending actuators touching the skin of single limb or individual or multiple whiskers, which moved at most 90 m in an anteriorto-posterior direction (a 2.6°angle of deflection). Visual stimulation was produced by a 1 ms pulse of light from a 435 nm LED placed at a consistent height and distance from the right eye. Averages of responses to sensory stimulation were calculated from 20 trials of stimulation with an interstimulus interval of 10 s. Awake mice were placed on a flat running wheel with the head stabilized by attaching the fixation bolt to a pole mounted on a base plate (Fig. 2Fa ) and were habituated for two to three sessions before imaging. A camera (30 Hz) was used to monitor behavior, confirming that the animals were awake and showed no signs of distress.
Analysis for wide-field imaging. All green fluorescent protein (GFP) indicators have excitation spectra that overlap with the absorption spectrum of hemoglobin (Hillman, 2007) , whereas red-shifted VSD signals are not significantly contaminated by heartbeat pulses and hemodynamic responses (Shoham et al., 1999; Petersen et al., 2003; Chan et al., 2015) . To remove the contribution of global hemodynamic and potential illumination fluctuations from iGluSnFR and GCaMP imaging, raw data were corrected with signal regression (Aguirre et al., 1998; Fox et al., 2009) for each pixel with the following:
where g(t) is a regressor, A i is the regression coefficient, and x i is the signal within the ith pixel after regression. Here, global signal regression (GSR) was used. Time traces of all pixels defined as brain were averaged to create a global brain signal, g GSR (t), and regressed from every pixel labeled as brain, as follows:
where N is the number of all brain pixels in the field of view (128 ϫ 128 pixels, 66.7 m per pixel).
To calculate the iGluSnFR and GCaMP responses evoked by sensory stimulation, images collected from the 20 trials were averaged and the normalized difference to the average baseline (ϳ50 ms) before stimulation was calculated (⌬F/F 0 ; region of interest (ROI) ϭ 667 m ϫ 667 m). GSR was applied for each trial to remove global fluctuations produced by blood volume changes and hemodynamic responses.
The peak of sensory-evoked responses was defined as the largest ⌬F/F 0 value averaged from a 10 ϫ 10 pixels ROI placed within V1 within 200 ms (iGluSnFR and VSD) or 1000 ms (GCaMP3 and GCaMP6s) after sensory stimulation. Peak amplitude measurements that were Ͻ3 times the SD of baseline fluctuations (ϳ50 ms) were classified as a failed response (peak ⌬F/F 0 ϭ 0) and were excluded from time to peak and decay 1/2 analysis. The decay 1/2 was calculated as the time to half the peak amplitude. Signal-to-noise ratio (SNR) was quantified as peak ⌬F/F 0 response over the SD during baseline and calculated on averaged responses (20 sweeps per animal).
Spontaneous activity of each ROI in the recording sequence was calculated by dividing each frame by the mean fluorescence of the entire time series (F 0 ). The result of iGluSnFR, GCaMP, and VSD signals was then temporally band-pass filtered to the indicated frequency bands using the Chebyshev in MATLAB (R2014b; The MathWorks) and then GSR was applied. To create the seed pixel correlation map, cross- correlation coefficient r values between the temporal profiles of a single selected pixel and all the other pixels of the ROI were calculated (White et al., 2011; Mohajerani et al., 2013) . For every map presented, spatial smoothing ( ϭ 67-134 m) was applied to improve contrast. Ongoing brain activity during active whisking or other significant movements (recorded by behavior camera) were excluded from spontaneous activity in awake animals. The total duration of spontaneous activity was maintained constant for all animals (20,000 frames recorded at 150 Hz) when generating correlation maps. Two-photon imaging and data analysis. Two-photon (2P) imaging was performed as described previously (Xie et al., , 2014 . Briefly, a small craniotomy (3 ϫ 3 mm) was made over the visual cortex. 2P excitation was performed with a Mai Tai Ti-sapphire laser and tuned to 920 nm to excite iGluSnFR . All experiments were performed using a 20ϫ objective (Olympus, numerical aperture ϭ 0.95) immersed in HEPES-buffered saline solution. Time series images were acquired at frame rates of ϳ20 Hz and at 100 -150 m depth from the surface of cortex. A median filter (radius, 1 pixel) was applied to reduce photon and photomultiplier tube noise. ⌬F/F 0 value was calculated to describe the responses upon 1 ms light flash stimulation. The stimulus light source was isolated from the detectors and we did not detect imaging artifacts from light stimulation. Spontaneous activity was processed the same way that it was for the wide-field imaging.
Pharmacology. A small craniotomy (3 ϫ 3 mm) was made over the visual cortex (n ϭ 4). Threo-beta-benzyloxyaspartate (TBOA; Tocris Bioscience), a glutamate transporter blocker, was dissolved into DMSO to 50 mM as stock solution and then diluted with HEPES-buffered saline solution to 500 M for direct cortical incubation. The compound was allowed to incubate for Ͼ20 min before starting imaging of spontaneous and visual stimulation-evoked activity.
Transcardial perfusion and brain slice imaging. Mice were transcardially perfused with PBS, followed by chilled 4% paraformaldehyde in PBS. Coronal brain sections (100 m thickness) were cut on a vibratome (Leica VT1000S). Images were acquired with a Zeiss Axiovert 200M fluorescence microscope using ZEN 2012 software.
Results

Cortical mapping of sensory-evoked responses by virally transduced iGluSnFR through a chronic window
We first used viral expression of iGluSnFR to characterize the in vivo kinetics of the iGluSnFR sensor using cortical responses to sensory stimulation. AAV1.hSyn.iGluSnFR was injected into the motor cortex, somatosensory cortex, and visual cortex ( mate in the vicinity of infected neurons, but is not targeted to a particular subcellular compartment. Three weeks after AAV injection, we observed a wide spatial expression of iGluSnFR covering almost the entire cortical hemisphere visible within the chronic window, including the somatosensory, motor, visual, and some of the association cortices (Fig. 2B) . As expected, there was higher expression near the injection sites (layer 1-3, Fig. 2C ). The distribution of viral iGluSnFR expression in deep layers (layer 4 -6) was not as uniform as in superficial layers (Fig. 2C) .
We imaged different modalities of sensory-stimulationevoked glutamate signals under 1.5% isoflurane anesthesia. We found that iGluSnFR was sensitive enough to detect responses to relatively weak stimuli, a single 1 ms piezo deflection of the whisker pad or tap to the plantar surface of forelimb or hindlimb (Fig. 2 D, E) , which was insufficient to elicit GCaMP3 signals (data not shown). We also imaged cortical glutamate levels after visual stimulation (1 ms light flash) in anesthetized and awake animals. Under both conditions, iGluSnFR signals can be clearly observed in the visual cortex ( Fig. 2 D, F ) . Interestingly, 1 ms visual stimulation induced consistent secondary responses at ϳ200 -400 ms in awake animals, which was not clearly observed in 1.5% isofluraneanesthetized animals (Fig. 2Eb,Fc) .
Regional mapping of sensory stimulation-evoked responses by transgenic iGluSnFR through a chronic window
To achieve a more uniform expression of iGluSnFR and to reduce methodological limitations related to viral injection (e.g., traumatic injury, inflammation, etc.), we acquired transgenic mice (Ai85) from the Allen Institute for Brain Science (Madisen et al., 2015) . The expression, kinetics, and in vivo function of these genetically encoded iGluSnFR animals was not previously functionally characterized. Using a tTA-based transcriptional amplification approach targeted to the TIGRE insertion locus, iGluSnFR was intersectionally and doubly regulated by both Cre and tTA to drive robust expression with improved precision to a targeted cell population (Huang and Zeng, 2013; Madisen et al., 2015) . Crossing Emx1-Cre with CaMKII-tTA and TIGREiGluSnFR ( Fig. 3Ai ) resulted in robust and uniformly expressed iGluSnFR within the chronic cortical window (Fig. 3Aii ). Brain sections of the positive transgenic mice confirmed robust expression in the cortex and hippocampus ( Fig. 3B ) (Madisen et al., 2015) . It was difficult to resolve subcellular expression of iGluSnFR in the cortex due to the dense expression of membrane protein ( Fig. 3B ; Marvin et al., 2013; Madisen et al., 2015) . iGluSnFR expression using our approach is designed to be doubly regulated by Emx-Cre and CaMKII-tTA to express selectively in the excitatory neurons of the cortex (Mayford et al., 1996; Gorski et al., 2002) and is consistent with other recently developed lines using the same approach (Madisen et al., 2015) . We performed sensory mapping of the Emx-CaMKIIiGluSnFR mouse under 1.5% isoflurane anesthesia. Stimulation was performed as in the virally infected mice using stimuli produced by single piezo deflections on the whisker pad, forelimb, and hindlimb plantar surface, as well as a 1 ms light flash for visual stimulation. Consistent with imaging from virally transduced iGluSnFR, we were able to detect responses in the cortex with high temporal and spatial resolution to even weak sensory stimuli in transgenic mice expressing iGluSnFR (Fig. 3C,D) . Again, visual stimulation evoked large iGluSnFR signals in the visual cortex (Fig. 3C,D) and awake animals exhibited a secondary delayed response at ϳ200 -400 ms (Fig. 3E) . A similar secondary response has been shown in the barrel cortex with whisker stimulation (Sachidhanandam et al., 2013) and in the visual cortex with light flash stimulation in awake mice (Funayama et al., 2015) , which are both associated with sensory perception. Moreover, as with virally delivered iGluSnFR, transgenically expressed iGluSnFR demonstrated stable sensory evoked responses over time, thereby permitting longitudinal imaging (Fig. 3Eb) .
Intracortical long-range connections are observed using seed pixel correlation maps generated from spontaneous activity in Emx-CaMKII-iGluSnFR mice Resting-state spontaneous activity provides samples of brain activity and requisite functional connectivity without requiring the testing subjects to engage in tasks and therefore has utility in physiological and pathological brain states (Zhang and Raichle, 2010; van den Heuvel and Hulshoff Pol, 2010 (Bero et al., 2012; . To our knowledge, this type of widefield characterization of spontaneous activity by glutamatergic signaling-presumably reflecting synaptic activity-has not been reported previously.
Imaging spontaneous iGluSnFR signals in the cortices of mice under 1.5% isoflurane revealed robust signals of spontaneous activity (Fig. 4Aa) . Processing the signals with GSR significantly reduced the artifacts related to breathing as well as heartbeatinduced blood-volume-related signals (Fig. 4Ab) . Activitydependent autofluorescence is not expected to make a large contribution to the measured fluorescence signals because of the higher absolute fluorescence associated with iGluSnFR (Díez-García et al., 2007; Vanni and Murphy, 2014) . We tested whether the mirrored bilateral activity identified with voltage and Ca 2ϩ imaging (Mohajerani et al., 2010; Vanni and Murphy, 2014) was reflected in glutamatergic signals as detected by iGluSnFR. Figure  4Aa shows synchronized iGluSnFR signals in the left and right hindlimb somatosensory cortex (red and blue trace), which were not synchronized with iGluSnFR signals in the (left/right) visual cortex (green trace, Fig. 4Aa ). Correlation maps of iGluSnFR signals in various frequency bands further confirmed the interhemisphere functional connectivity, as well as local connectivity (Fig. 4B) . Placing the seed pixel in the center of sensory cortices, we generated maps using iGluSnFR ( 
Blocking glutamate transporter amplifies sensory stimulation evoked and spontaneous iGluSnFR signals
Blocking excitatory amino acid transporter 1 and 2 (EAAT1 and EAAT2) with TBOA (Shimamoto et al., 1998) increases both the amplitude and the decay time constant of the spontaneous iGluSnFR events in the inner plexiform layer bipolar cells . To confirm that wide-field iGluSnFR signals can also be manipulated by blocking glutamate reuptake in mouse cortex in vivo, 500 M TBOA was applied to the craniotomy over the visual cortex (Fig. 5A ) and was allowed to incubate for Ͼ20 min before imaging spontaneous and visual-stimulation-evoked activity. We previously demonstrated the cortical incubation enables drug diffusion into as deep as layer 5 (Xie et al., 2014) . It should be mentioned that the open skull craniotomy (Fig. 5A ) is relatively more invasive than the intact skull window (Fig. 1B) . Blocking glutamate reuptake significantly increased the amplitude of iGluSnFR signals in response to 1 ms visual stimulation (first peak amplitude: baseline vs TBOA: 0.77 Ϯ 0.12% vs 1.17 Ϯ 0.22%, p Ͻ 0.05, mean Ϯ SEM, n ϭ 4, Fig. 5 B, C) and during spontaneous activity in the visual cortex (Fig. 5Db) . In addition, the SD map during a period of 133 s spontaneous activity exhibited an ϳ2-fold increase within the craniotomy where TBOA had access to tissue (Fig. 5Da) . These results demonstrate that blocking glutamate reuptake amplifies sensory stimulation-evoked and spontaneous iGluSnFR signals in wide-field imaging, which is consistent with results from cellular imaging in retina .
Two-photon in vivo imaging reveals the dense expression of iGluSnFR and confirms visual-stimulation-evoked responses in Emx-CaMKII-iGluSnFR mice
2P in vivo imaging was applied to explore the cellular distribution of iGluSnFR expression and the cellular compartments where the spontaneous and evoked-activity occur in the visual cortex of Emx-CaMKII-iGluSnFR mice. Consistent with brain section histology (Fig. 3B) , 2P imaging revealed a dense expression of iGluSnFR spanning a depth of at least 300 m in visual cortex (Fig. 6A) . Consistent with wide-field imaging results, we observed a general increase in fluorescence intensity (Ͼ1% ⌬F/F 0 ) from neuropil in superficial layers (imaged at a depth of 100 -150 m) of visual cortex after a 1 ms light flash visual stimulation in 1% isoflurane-anesthetized Emx-CaMKII-iGluSnFR mice (Fig. 6B) . In addition, 2P imaging also revealed spontaneous iGluSnFR signals (Fig. 6C) . Despite challenges with respect to resolving the cellular origin of the iGluSnFR signals, 2P imaging resulted in improved signal, in part due to lessened blood volume artifacts, compared with wide-field.
iGluSnFR signal has faster kinetics for regional imaging of spontaneous and sensory-evoked responses than GCaMP3 and GCaMP6s
A key to obtaining real-time measures of ongoing neuronal activity and processing using imaging techniques is to employ the sensors with high sensitivity and fast kinetics. We next compared the response amplitude and kinetics of iGluSnFR signals with GCaMP3 signals and VSD signals. Although GCaMP3 signals have smaller amplitude than the fastest Ca 2ϩ sensor, GCaMP6f (by ⌬F/F 0 under physiological conditions), they share a similar rise time ( peak : GCaMP3 137 Ϯ 4 ms vs GCaMP6f 80 Ϯ 35 ms, 10 action potentials) and decay time ( 1/2 : GCaMP3 597 Ϯ 8 ms vs GCaMP6f 400 Ϯ 41 ms, 10 action potentials) (Chen et al., 2013b) . For comparison, 10 action-potential-associated iGluSnFR signals showed faster kinetics with 15 Ϯ 11 ms rise 1/2 and 92 Ϯ 11 ms decay 1/2 .
We filtered the imaging data into delta (0.1-4 Hz), theta (4 -8 Hz), and alpha bands (8 -12 Hz) (van Drongelen, 2007) to compare functional connectivity maps developed from seeds (Mohajerani et al., 2013) in the right hindlimb cortex. We applied the same image processing protocols to all sensors. It is worth nothing that iGluSnFR signals have superior sensitivity and kinetics for interhemisphere functional connectivity in the alpha band, whereas other sensors failed to resolve this (Fig. 7A) . Moreover, the functional connectivity maps of iGluSnFR signals were also more robust within theta bands compared with other sensors (Fig. 7A) . To compare the kinetics of sensory-evoked responses between various sensors, a 1 ms light flash with same intensity was applied. The SNR of 20 averaged trials was comparable across iGluSnFR, VSD, and GCaMP3 (Table 2 ). The kinetics (time to peak and decay 1/2 ) of iGluSnFR signals were 4 -8 times faster than GCaMP3 and GCaMP6s signals and were close to the kinetics of the VSD signal with similar time to peak value and the ϳ2-fold increased decay 1/2 value (Fig. 7B , Table 2 ).
Discussion
We report the in vivo, wide-field imaging of a genetically encoded glutamate indicator, iGluSnFR , in awake and anesthetized mice. We used longitudinal mesoscopic imaging of iGluSnFR expressed in the dorsal cerebral cortex using an intact skull chronic window preparation (Guo et al., 2014a; Silasi and Murphy, 2014; Vanni and Murphy, 2014). iGluSnFR reports extracellular glutamate concentration that we interpret as a surrogate of glutamatergic synaptic activity. Using both viral delivery and transgenic approaches to express iGluSnFR in cortical neurons, our data indicate that iGluSnFR signals exhibit rapid kinetic properties and high SNR for reporting sensory-evoked cortical responses and spontaneous activity, which were both amplified by blocking glutamate transporter. By comparing evoked cortical responses across iGluSnFR, GCaMP3, GCaMP6s, and VSD signals, we found that iGluSnFR provides superior temporal kinetics than available state-of-the-art genetically encoded sensors for regional imaging of event-related activity. Although current GCaMPs, including GCaMP6f/s, have a greater signal (⌬F/F 0 ), GCaMP3, which we have tested the most extensively, has similar reported decay kinetics to GCaMP6f (Chen et al., 2013b) . Moreover, functional connectivity assessed by seed-pixel correlation maps generated from spontaneous iGluSnFR signals was consistent with maps described from GCaMP or VSD signals. Our results indicate that mesoscopic cortical imaging of iGluSnFR will enable longitudinal studies of synaptic activity and cortical circuits during plasticity paradigms or in pathological brain states with higher temporal resolution. 
Interpretation of iGluSnFR signals
The signal from iGluSnFR likely reflects both the dynamics of glutamate release and clearance (Haustein et al., 2014) . When changes are observed in regional iGluSnFR signals (or even at the cellular level), it is difficult to separate the contribution of release and reuptake. Potentially, the rapid rise time of the signals is more dependent on glutamate release and the decay period reflects unbinding, diffusion, and glutamate clearance by reuptake. Consistent with this, cellular imaging results have also shown that the blockade of reuptake lengthens iGluSnFR decay responses by approximately one order of magnitude Haustein et al., 2014) . We observed amplified visual stimulationevoked regional iGluSnFR signals after the reduction in glutamate reuptake with 500 M TBOA. However, TBOA did not lengthen the decay time (Fig. 5B) , suggesting a nuanced interpretation of the factors determining regional iGluSnFR signal kinetics in vivo. It is possible that reuptake is not a rate-limiting factor for the kinetics of visual responses from a glutamate perspective. Using 2P imaging, we investigated the nature of wide-field iGluSnFR signals during spontaneous activity and after sensory stimulation (Fig. 6) . This approach confirms a predominantly neuropil origin of iGluSnFR signals throughout the superficial cortical layers. Unfortunately, dense iGluSnFR expression in cortical excitatory neurons prevented identification of cellular iGluSnFR signals in Emx-CaMKII-iGluSnFR mice. The fluorescence is present in membrane compartments, making it difficult to resolve individual processes or somata. However, membrane localization is critical for monitoring extracellular glutamate. Membrane fluorescence contrasts with the relatively larger volumes that soluble probes such as GCaMPs occupy, making discrete somata relatively easy to resolve. When sparsely expressed, individual dendrites can be visualized using iGluSnFR imaging ; however, the probe is not selectively targeted and is expected to be present in both axonal and dendritic compartments Haustein et al., 2014) . Future in vivo studies using sparse expression strategies will improve our understanding of local iGluSnFR signals.
Comparison with other genetically encoded sensors for mesoscopic imaging
Signal strength and kinetic properties of activity sensors are crucial for informative studies of event-related responses and cortical dynamics in vivo. We characterize these responses here using sensory-evoked responses and spontaneous brain activity. Various genetically encoded sensors have been developed (Akemann et al., 2010; Chen et al., 2013b; Huang and Zeng, 2013), but their usage in imaging at the mesoscopic level have not been carefully examined and compared. When tested in vitro, these recombinant glutamate sensors can have millisecond activation rates and Ͻ100 ms decay kinetics. In addition to its specificity for glutamate signaling , we found that iGluSnFR had the best kinetic properties for monitoring regional activity compared with other state-of-the-art genetically encoded sensors such as GCaMPs (Chen et al., 2013b; Vanni and Murphy, 2014; Madisen et al., 2015) . This could be attributed to the fast clearance of extracellular glutamate, as well as the faster on and off rate of iGluSnFR compared with Ca 2ϩ signaling and the kinetics of GCaMPs. Given that iGluSnFR reflects rapid excitatory neurotransmitter-related transmission, it may be suitable to the study of synaptic excitation/inhibition balance during wakefulness (Haider et al., 2013) . Although visual responses to single flash stimuli offer the ability to extend imaging to awake animals (noncontact and less invasive), single brief stimuli directed to the whisker or limbs are likely best for evaluating the speed of processing.
iGluSnFR can reveal frequency-dependent mesoscopic bilateral functional connectivity The seed-pixel correlation maps of iGluSnFR over 0.1-12 Hz were generally similar to what we found with GCaMP3 and VSD imaging using either 0.1-1 Hz or 0.5-6 Hz frequency spontaneous activity, respectively (Mohajerani et al., 2013; Vanni and Murphy, 2014) . These spontaneous activity maps reflect structural connections within the cortex (Mohajerani et al., 2013; Oh et al., 2014) or areas receiving common upstream drive. Due to its rapid kinetics, we suggest that the regional activity of spontaneous iGluSnFR signals will be able to report bilateral homotopic functional connectivity that are associated with higher frequency events in particular in up to 12-30 Hz (Harris and Mrsic-Flogel, 2013; Mohajerani et al., 2013) . Interestingly, although iGluSnFR may be able to assess functional connectivity in higher-frequency bands of activity, initial analysis suggests that long-distance functional connectivity can be well represented in ϳ1 Hz activity. However, close inspection of maps reveals that mirrored homotopic maps may be less prevalent at 12-30 Hz, indicating a frequency dependence to laterality (van Kerkoerle et al., 2014) . The mesoscopic imaging of fast cortical iGluSnFR signals may assist monitoring information flow among cortical regions during behavior tasks (Matyas et al., 2010; Chen et al., 2013a; Guo et al., 2014b; Li et al., 2015) . Consistent with this proposal, we readily observe both a primary and late secondary visual response (peaks at 200 -250 ms) using iGluSnFR in vivo that may be related to intracortical reverberation of activity (Sachidhanandam et al., 2013; Funayama et al., 2015) in awake states.
Signal processing considerations
All of the single-wavelength GFP-based sensors, including GCa MPs and iGluSnFR, suffer from breathing-induced, heartbeat-induced, and hemodynamic artifacts (Hillman, 2007) . Dual wavelength voltage-dependent Forster resonance energy transfer (FRET) sensors such as voltage-sensitive fluorescent proteinButterfly 1.2 or ratiometric Yellow Cameleon have the advantage to parse these other signals by applying signal equalization (Horikawa et al., 2010; Akemann et al., 2012) , principal component analysis (Carandini et al., 2015) , or other ratiometric methods (Minderer et al., 2012; Chen et al., 2013a) . In our case, GSR (Aguirre et al., 1998; Fox et al., 2009) *The decay time reflects the time to 50% of peak amplitude, which for Ai85 and RH1692 occurred over the fast initial component of the response (see Figure 7B ).
global neuronal activity (Schölvinck et al., 2010) . Therefore, interpretation of GSR-regressed data can require caution when slow signals and in particular when reductions in signal are evaluated (not the case for present work). Conversely, ratiometric optical signals of FRET-based glutamate sensors (Hires et al., 2008) may provide a convenient means to reduce movement and hemodynamic noise, but they have to be adapted to match the sensitivity of iGluSnFR . Background signals due to flavoprotein autofluorescence, as previously proposed (Díez-García et al., 2007; Husson et al., 2007) , and blood volume artifacts are unlikely to have contaminated iGluSnFR data significantly given that these artifacts are relatively slow and have been shown to minimally affect less sensitive and slower GCaMP3 signals (Vanni and Murphy, 2014) . Control experiments (Vanni and Murphy, 2014) performed in wild-type nonfluorescent mice and activity-insensitive GFP mice (Feng et al., 2000) demonstrate that flavoprotein autofluorescence responses are much slower than iGluSnFR signals and only contribute to Ͻ3% of the GFP responses in Emx-GCaMP3 mice. Signal fluctuations resulting from the absorption of the blue excitation light and green emission fluorescence by local hemoglobin concentration (estimated from GFP mice) was less pronounced compared with GCaMP3 signal (SD: 8% relative to Emx-GCaMP3 spontaneous activity; Vanni and Murphy, 2014) . Given that iGluSnFR signals are of comparable magnitude to GCaMP3 (but have faster kinetics), we expect these artifacts to contribute an even smaller percentage of variance to iGluSnFR signals.
In conclusion, longitudinal mesoscopic imaging of extracellular glutamate signals provides a new tool to monitor synaptic activity, with faster kinetics and neurotransmitter specificity, compared with other genetically encoded sensors such as GECIs. iGluSnFR has utility in normal physiology, as well as neurologic and psychiatric pathologies that are associated with glutamatergic abnormalities.
